FM
PLXP

Fondren Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Fondren Management’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,000
Closed -$23K – 66
2020
Q1 		$23K Hold
10,000
– – 0.06% 69
2019
Q4 		$44K Buy
+10,000
New +$47K 0.05% 83

Other funds holding PLXP

Park West Asset Management
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
University of Texas/Texas AM Investment Management Co (UTIMCO)
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Heritage Way Advisors
Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Cranbrook Wealth Management
Cranbrook Wealth Management Bloomfield Hills, Michigan $534M AUM 18.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
1776 Wealth
1776 Wealth Atlanta, Georgia $284M AUM 21.82% 1-Year Est. Return

Fondren Management's PLXP Position: Q2 2020 in Review

Fondren Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2020, closing a stake of 10,000 shares — an estimated $23K sold.

Fondren Management first reported a position in PLXP in Q4 2019 and held it in 2 quarters. The position peaked at $44K in Q4 2019. 18 funds tracked by Wall St. Rank hold PLXP as of Q2 2020.

  • Fondren Management reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Fondren Management sold 10,000 PLx Pharma Inc. Common Stock shares in Q2 2020, an estimated $23K.
  • Fondren Management first reported a position in PLx Pharma Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Fondren Management's PLx Pharma Inc. Common Stock position peaked at $44K in Q4 2019.
  • 18 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2020.

Based on Fondren Management's 13F filing for Q2 2020, filed 14 Aug 2020.